The State Council joint defense and control mechanism answers the question related to vaccination

my country's new crown vaccine is safe and effective -the State Council joint defense and control mechanism answers the question related to vaccination

Omikon BA.5 Asian branches spread to more than 100 countries and regions around the world, leading to an increase in the number of infections, hospitalization, and severe illnesses, and China's foreign defense input pressure continued to increase.

What is the progress of the new crown vaccine in my country? When will the Omikon vaccine appear? Focusing on the related issues of vaccination, the State Council's joint prevention and control mechanism held a press conference on the 23rd to respond to the system.

The current party and state leaders have completed the domestic new crown vaccine vaccination

Zeng Yixin, deputy director of the National Health and Health Commission, introduced at the press conference of the State Council ’s joint prevention and control mechanism on the 23rd that as of now, 31 provinces (autonomous regions, municipalities) and the Xinjiang Production and Construction Corps have reported a total of 92.1 in vaccination. %, The whole vaccination rate is 89.7%, and the enhanced immune vaccination rate is 71.7%.

In terms of vaccination for the elderly, at present, at least 1 dose of vaccination rates in my country over 60 years of age are 89.6%, the entire vaccination rate is 84.7%, and the immune vaccination rate is 67.3%.

"my country's current party and state leaders have completed the vaccination of the new crown vaccine, and the vaccination is my country's domestic vaccine." Zeng Yixin introduced, which fully illustrates the high attention of our leaders to the prevention and control of the epidemic, and the new crowns produced in my country to produce in China High trust in vaccine.

Multiple technical routes in my country carry out the research and development of Omikon vaccine

Feng Zijian, Executive Vice President and Secretary -General of the Chinese Association of Prevention Medicine, said that many technical routes in my country have carried out the research and development of the unit price and multi -price Omikon mutant plant.

According to reports, the rapidly moving price of Omikon variants has been approved by clinical trials and is conducting clinical trials in Zhejiang, Hunan, Hong Kong and other places. The rapid progress of tetramid restructuring protein vaccine has been approved by Phase III clinical trials in the UAE, and related research has been launched. In addition, the research on the broad -spectrum new crown virus vaccine has also been deployed. The rapid progress of vaccine has been approved by clinical trials and launched related research.

"my country's vaccine still has a good protective effect on the severe disease and death caused by the mutant strains." Feng Zijian said that the research and development of the Omicor Rong mutant plant vaccine is steadily promoted. You can quickly start emergency use procedures and provide vaccination. As for whether it is necessary to vaccinate and when to take vaccination specifically for Omikon -containing variants, this problem is not only in my country, but also internationally studying, mainly to study virus mutation and immune escape.

Vaccinating new crown vaccines will not cause leukemia and diabetes

Wang Fusheng, the director of the Fifth Medical Center of the PLA General Hospital and an academician of the Chinese Academy of Sciences, said that inoculation of new crown vaccines will not cause the occurrence of leukemia and diabetes, nor will it affect the genetic development of human body as some network information. Causes antibody dependence to enhance.

Wang Fusheng said that the various substances in the vaccine are safe to the human body and will not directly cause disease. The reagents used in the vaccine production process have been strictly verified and reached the standard by relevant institutions. At present, the largest number of new crown vaccines in my country have sufficient security guarantee and have been recognized by international organizations.

In addition, clinical monitoring and statistical data show that during the four years before and after the new crown epidemic, the number of diabetes and leukemia was basically the same and the number of hospitalizations was basically the same, and there was no significant change.

Wang Fusheng said that in the context of large -scale vaccine vaccination, a large number of prevention of vaccination and the natural occurrence of certain serious diseases occur in time. It is an inevitable phenomenon in time. It can be simply calculated that if the new crown vaccine really causes diabetes and leukemia, the number of consultations and inpatients will increase significantly, but from the data of actual monitoring and clinical statistics, this phenomenon will not be seen. Essence

Both homologous strengthening and sequential enhancement can greatly improve the protection effect

Zheng Zhongwei, director of the Science and Technology Development Center of the National Health and Health Commission and the research and development of the research and development of the scientific research research and research group, said that whether the vaccination (the same technical route vaccine was strengthened) or the sequence was enhanced (the vaccine of the different technical routes was strengthened) , Can greatly improve the protection of the new crown vaccine.

Zheng Zhongwei introduced that it is not necessary to simply to strengthen immunity and sequence to strengthen immunity. Regardless of the inoculation or sequentially enhanced vaccination, the effects of prevention, severe and death protection effects are quite significant. It is possible to take homology strengthening or sequential enhancement. I hope everyone can actively strengthen inoculation.

When answering the question of the selection of vaccine doses, Wang Junzhi, an expert group of the State Council ’s joint defense and control mechanism scientific research and research and research and development team, said that the animal protection experiments and human clinical trial data during the research and development of the new crown vaccine in my country When the dosage of the vaccine is very good in safety indicators when 3 micrograms to 5 micrograms, the rotation rate of antibody yang is close to 100%, and the antibody titer has reached the expected level, which means that its safety indicators and effective indicators meet national regulations. Standards.

- END -